Illustration of the tumur microenvironment in triple-negative breast
$ 15.99 · 4.6 (478) · In stock
Download scientific diagram | Illustration of the tumur microenvironment in triple-negative breast cancer. Notes: Data from Zhou Y, Tian Q, Wang BY, Yang J, Zhao SD, Yang J. The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC? Adapted from Zhou Y, Tian Q, Wang BY, Yang J, Zhao SD, Yang J. The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC. Eur Rev Med Pharmacol Sci. 2021;25(7):2885-2897. Creative Commons. 7 from publication: Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management | Triple negative breast cancer (TNBC) is a subtype of breast cancer which does not express or expresses a minimum amount of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) protein. TNBCs include a heterogenic group of | Breast Cancer Management, Triple Negative Breast Neoplasms and Tumor-Infiltrating Lymphocytes | ResearchGate, the professional network for scientists.
The Basics of the Tumor Microenvironment
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents - ScienceDirect
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressiveness - Materials Today
Frontiers Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment - ScienceDirect
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity. - Abstract - Europe PMC
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects. - Abstract - Europe PMC
Cancers, Free Full-Text
Epigenetic drugs contribute to turning cold tumors into hot. Cancer
IJMS, Free Full-Text
Cancers, Free Full-Text
Interrogating the Complexities of the Tumor Microenvironment
Schematic illustration of pH activation of nanoparticle by tumor